Literature DB >> 17185626

Endogenous secretory receptor for advanced glycation endproducts levels are correlated with serum pentosidine and CML in patients with type 1 diabetes.

Junnosuke Miura, Yasuhiko Yamamoto, Mari Osawa, Takuo Watanabe, Hideto Yonekura, Yasuko Uchigata, Hiroshi Yamamoto, Yasuhiko Iwamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17185626     DOI： 10.1161/01.ATV.0000251533.18013.67

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  9 in total

1.  The possible role of esRAGE and sRAGE in the natural history of diabetic nephropathy in childhood.

Authors:  Cosimo Giannini; Ebe D'Adamo; Tommaso de Giorgis; Valentina Chiavaroli; Alberto Verrotti; Francesco Chiarelli; Angelika Mohn
Journal:  Pediatr Nephrol       Date:  2011-08-26       Impact factor: 3.714

2.  Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study.

Authors:  J W M Nin; I Ferreira; C G Schalkwijk; M H Prins; N Chaturvedi; J H Fuller; C D A Stehouwer
Journal:  Diabetologia       Date:  2009-01-30       Impact factor: 10.122

3.  Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases.

Authors:  Hidenori Koyama; Hiroshi Yamamoto; Yoshiki Nishizawa
Journal:  Biomark Insights       Date:  2007-09-17

4.  Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy.

Authors:  Masayoshi Takeuchi; Jun-Ichi Takino; Sho-Ichi Yamagishi
Journal:  J Ophthalmol       Date:  2010-06-22       Impact factor: 1.909

Review 5.  Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2014-03

6.  Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects.

Authors:  K Nakamura; S I Yamagishi; T Matsui; H Adachi; M Takeuchi; T Imaizumi
Journal:  Clin Exp Med       Date:  2008-01-11       Impact factor: 3.984

Review 7.  RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases.

Authors:  Hidenori Koyama; Hiroshi Yamamoto; Yoshiki Nishizawa
Journal:  Mol Med       Date:  2007 Nov-Dec       Impact factor: 6.354

8.  Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality.

Authors:  Yanzi Cheng; Jiwen Zhong; Yang Xiang; Fan Zeng; Dehong Cai; Ling Zhao
Journal:  Clin Interv Aging       Date:  2014-11-19       Impact factor: 4.458

9.  Circulating Irisin and esRAGE as Early Biomarkers of Decline of Metabolic Health.

Authors:  Elena Dozio; Elena Vianello; Clementina Sitzia; Federico Ambrogi; Stefano Benedini; Silvia Gorini; Benedetta Rampoldi; Roberta Rigolini; Lorenza Tacchini; Massimiliano Marco Corsi Romanelli
Journal:  J Clin Med       Date:  2020-02-06       Impact factor: 4.241
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.